Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Super Transplantation for Severe Beta-Thalassemia
NCT06734520Phase 1Recruiting
- Start
- Oct 2024
- Primary completion
- Jul 2029
- Modality
- Cell Therapies
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of peripheral blood mononuclear cells in beta thalassemia. Primary endpoint: chimeric status at 1 year. Started Oct 2024; status: recruiting.
02
Drugs
peripheral blood mononuclear cells
03
Conditions
beta thalassemia
Beyond the preview
Go deeper on NCT06734520.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06734520.